Gabapentin Reduces Analgesic Consumption, Nausea & Vomiting and 24-Hour Pain After Arthroscopy .
The analgesic evaluation of gabapentin for arthroscopy: A meta-analysis of randomized controlled trials
Medicine (Baltimore) . 2021 May 21;100(20):e25740Five randomized controlled trials containing 346 patients scheduled to undergo arthroscopy were included in this meta-analysis comparing administration of gabapentin (n=171) to placebo (n=175) for post-operative pain relief. The primary outcome of interest was pain measured at 6 and 24 hours post-surgery. Secondary outcomes of interest included analgesic consumption, incidence of dizziness, and incidence nausea and vomiting. Meta-analysis results revealed significantly favorable pooled pain scores at 24-hours in the gabapentin group vs placebo (p=0.005), but not at 6-hours (p=0.11). Pooled secondary outcomes except for incidence of dizziness (p=0.75) were significantly favored in the gabapentin group compared to placebo (p<0.05 for both).
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
